Abstract:The Co-administration of multiple drugs can enhance the efficacy of disease treatment by reducing drug resistance and side effects. However, it also raises the risk of adverse drug interactions, presenting a challenging problem in healthcare. Various approaches have been developed to predict drug-drug interactions (DDIs) by leveraging both knowledge graphs and drug attribute information. While these methods have shown promise, they often fail to effectively capture correlations between biomedical information in the knowledge graph and drug properties. This work introduces a novel end-to-end DDI predictor framework based on generative adversarial networks. This framework utilizes a message-passing neural network to capture molecular structure information while employing the knowledge-aware graph attention network to capture the representation of drugs in the knowledge graph through considering the importance of different multihop neighbor nodes and relationships. The dual generative adversarial networks employ two generators and two discriminators in knowledge graph embedding and molecular topology embedding for adversarial training to capture the interrelations and complementary knowledge between molecular structure information and semantic information from the knowledge graph. comprehensive experiments have demonstrated that the proposed method outperforms state-of-the-art algorithms in binary classification, with improvements of 1.0% in accuracy, 0.45% in area under the receiver operating characteristic curve (AUC), 0.24% in area under the precision-recall curve (AUPR), and 0.98% in F1 score. Furthermore, for multiclass classification tasks, improvements were observed across various evaluation metrics, including 0.9% in accuracy, 0.25% in macro precision, 0.2% in macro recall, and 0.28% in macro F1. Additionally, ablation studies were conducted to showcase the effectiveness and robustness of our method in DDI prediction tasks.

DDI Prediction via Heterogeneous Graph Attention Networks

Attention-based Cross Domain Graph Neural Network for Prediction of Drug-Drug Interactions.

Prediction of Drug-Drug Interaction Using an Attention-Based Graph Neural Network on Drug Molecular Graphs

HyGNN: Drug-Drug Interaction Prediction via Hypergraph Neural Network

DGANDDI: Double Generative Adversarial Networks for Drug-Drug Interaction Prediction

Directed graph attention networks for predicting asymmetric drug–drug interactions

Drug-drug Interaction Prediction with Graph Representation Learning

Heterogeneous Graph Attention Network for Drug-Target Interaction Prediction

RGDA-DDI: Residual graph attention network and dual-attention based framework for drug-drug interaction prediction

H2D: Hierarchical Heterogeneous Graph Learning Framework for Drug-Drug Interaction Prediction

DRGATAN: Directed Relation Graph Attention Aware Network for Asymmetric Drug-Drug Interaction Prediction

Prediction of drug-drug interaction events using graph neural networks based feature extraction

Attention-Based Learning for Predicting Drug-Drug Interactions in Knowledge Graph Embedding Based on Multisource Fusion Information

MASMDDI: multi-layer adaptive soft-mask graph neural network for drug-drug interaction prediction

Dual-Channel Learning Framework for Drug-Drug Interaction Prediction Via Relation-Aware Heterogeneous Graph Transformer

Predicting Drug-Target Interactions Via Dual-Stream Graph Neural Network

Integrated Knowledge Graph and Drug Molecular Graph Fusion Via Adversarial Networks for Drug-Drug Interaction Prediction.

Graph Distance Neural Networks for Predicting Multiple Drug Interactions

MGDDI: A multi-scale graph neural networks for drug-drug interaction prediction

Hierarchical Multi-Relational Graph Representation Learning for Large-Scale Prediction of Drug-Drug Interactions

DMHGNN: Double Multi-View Heterogeneous Graph Neural Network Framework for Drug-Target Interaction Prediction